Thursday, 23 May 2019

Edison Investment Research Posts Update on BioLargo for First Quarter 2019

Edison Investment Research Group published an update on BioLargo, Inc. today internationally through their distribution channels.

You can read the full report at their website HEREand you can also access their original analyst report on BioLargo HERE.









**********************

BioLargo continues to make progress in its goal to establish its various subsidiaries as independent businesses. Odor-No-More recorded revenue of $301,000 for Q119 (of $364,000 total), down 10.7% from Q418. It cited lumpiness in its sales pattern caused by the timing of orders, weather and manufacturing, and the fact that approximately 20% ($68,000) of orders were in process at the end of the quarter. This business is expanding with new distribution agreements in the waste handling and cannabis industries. BioLargo Water has placed it first Advanced Oxidation System (AOS) treatment train, and Clyra Medical will run a 30-day animal study to support a 510(k) application for its wound treatment product.

New deals: Waste handling and cannabis

Odor-No-More signed its fourth national distribution agreement with a major waste handling company and was included on the partner’s purchasing portal. Inclusion in the purchasing portal will make the product available to all operators in the company’s network. The company also announced additional details regarding its initiative to market its CupriDyne Clean products to the cannabis industry: it has signed a five-year distribution agreement with Cannabusters, Inc. to provide CupriDyne Clean as a white-label product. We expect the cannabis industry to grow to over $35bn in 2024, and for it to be a major odor control market. Cannabis cultivation results in the release of large amounts of volatile organic terpenes into the air, which are potent odorants and a potential environmental or health risk.

Clyra in the final stretch

Following FDA feedback that was received shortly before the company’s Q119 report, management is confident that the last piece of data needed to complete the 510(k) application for its wound care product will be a 30-day animal safety study. The company recently completed a preliminary animal study confirming the study protocol, which showed no adverse effects. Once the data from the 30-day animal study is submitted to the FDA, a response is expected in less than 30 days.

AOS: First pilot up and running


BioLargo announced that the first all-in-one AOS water treatment train was placed at a commercial facility as part of its pilot program, a poultry and livestock farm based in Alberta, Canada (Sunworks Farm). This is the second AOS unit placed (the first was its brewery pilot), but the first in which a complete water treatment solution was placed. We expect this program to provide useful feedback on the system and to help establish its utility in a real-world setting.

Thursday, 16 May 2019

BioLargo Quarterly Report Highlights Commercial Progress

Westminster, CA – May 16, 2019 – BioLargo, Inc. (OTCQB:BLGO), developer of sustainable products and a full-service environmental engineering company, today announced the filing of its 10-Q quarterly report. As always, company management encourages its stockholders to review the quarterly report which is linked HERE.

Highlights of the company’s commercial progress:













  • Odor-No-More:
    • Revenues for three months ended March 31, 2019 were $364,000, a $101,000 increase over the same period in 2018 – revenue figures do not include $68,000 worth of orders in process as of March 31 which will record in Q2
    • Fourth national purchasing agreement with a waste handling industry leader went live in late March on its centralized purchasing portal, clearing the opportunity for customer operations staff to begin purchasing CupriDyne® Clean
    • Signed a 5-year white-label distribution agreement to sell its disruptive odor and VOC control product CupriDyne Clean into the cannabis and hemp industries under the brand name “Cannabusters” with Cannabusters, Inc., a sister company to Mabre Air Systems 
    • Received the first order for its new product named “CupriDyne Clean Wash” as a one-step solution to wash out trash bins, storage containers and compactors








  • Clyra Medical Technologies:
    • Received the last material request by FDA for the company’s first 510(k) application - commencing a 30-day animal study to confirm that the Clyra product has no adverse effects on wound healing (preliminary study confirmed no adverse effects) (legal disclaimer - while management remains confident that Clyra will ultimately receive premarket clearance for this product, it can make no assurance or prediction as to the success of these efforts)
    • $3M over the past two years has been invested organizing and preparing its antimicrobial and stem cell therapy products to launch into the $2.5B total addressable market
    • Additional technologies are being considered for licensure as Clyra prepares to go to market
















  • BioLargo Water: 
    • Installed its first fully functional Advanced Oxidation System (AOS) treatment train on-site at a poultry and livestock farm in Alberta in the company’s first pre-commercial demonstration pilot
    • Grants awarded total 66 and counting and exceed $3 million in total financial support for the AOS technology
    • Several peer-reviewed publications about the AOS are in progress and will be submitted to high-impact academic journals











  • BioLargo Engineering, Science & Technologies (BLEST):
    • Recently awarded a $100,000 EPA SBIR Phase I grant to develop new methods of eliminating per- and poly-fluoroalkyl substances (PFAS), a group of water contaminants associated with serious health problems including cancer 
    • Playing a critical role supporting BioLargo’s other operating units, as external service engagements with clients continue to expand

BioLargo President & CEO Dennis P. Calvert commented, “Our investments of time and approximately $23 million total capital are now beginning to bear financial fruit and, yet, our current success is only the tip of the iceberg. With the support of our investors we have managed to fully develop and validate three sustainable platform technologies that are destined to serve as cornerstones upon which to build a significant life sciences technology company. We have assembled a team of highly skilled professionals and partners to help us break through the barriers to entry and commercialize our disruptive technologies through strategies including licensure, joint venture, and direct sales.  Notwithstanding the incredible challenges we have faced, we know that our patented technologies hold a bright future and it is our privilege to shepherd them to commercial success.”

About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic wounds to promote infection control and regenerative tissue therapy.

Contact Information
Dennis Calvert President and CEO BioLargo, Inc. 888-400-2863

Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Tuesday, 7 May 2019

BioLargo’s CupriDyne Clean and BioLargo Engineering at Waste Expo 2019



Our team is out in force this week at Waste Expo in Las Vegas! Waste Expo is the largest waste handling conference in the United States – it’s attended by the biggest players in solid waste handling, composting, recycling, and more. Our odor division Odor-No-More is showcasing the company’s disruptive odor and VOC control product CupriDyne Clean, which delivers instant odor elimination without the need for fragrances and at lower cost than competitors. Learn more about CupriDyne Clean online here. CupriDyne Clean already has national purchasing agreements signed with four of the top solid waste handling companies in the U.S.

BioLargo’s engineering division is also exhibiting at this year’s Waste Expo. BioLargo’s engineers have decades of experience solving environmental engineering challenges for customers across a vast range of industries, including in waste handling. Their appearance at Waste Expo in 2019 is part of an effort for the engineering division to offer expanded environmental engineering services within the waste handling market where BioLargo’s odor and VOC control division is already selling its disruptive products.





















Monday, 6 May 2019

The AOS Demonstration Pilot and What it Means for BioLargo’s Future


The On-Site AOS Treatment Train

We recently built and installed a sophisticated water treatment system featuring our Advanced Oxidation System (AOS) at a poultry and livestock farm near Edmonton, AB (Sunworks Farm). This pre-commercial pilot will be the first in-field operating AOS system. It is hard to overstate how proud we are of our team for this milestone in the development cycle of the AOS. It’s equally hard to overemphasize how important this milestone is to the commercialization of this amazing technology. When we talk about our AOS technology with stakeholders and investors, a common refrain we hear is, “Sure, but when’s this thing getting out of the research lab and into the real world?” With the news of this treatment train installation, we can answer, “Now”.


















This AOS treatment train has profound implications on both the technological progress of the AOS technology as well as our ability to monetize the AOS. From a technological standpoint, this is a full treatment train containing everything a client needs to treat their wastewater to discharge standards set by regulators. It’s also capable of handling the flowrates required by livestock facilities like this one and is easily scalable to higher flowrates with additional reactors in the treatment train. And importantly, the treatment train is robust enough to function over long periods of time at this poultry farm in any weather. This is a far cry from the lab prototypes that came before. With this new AOS treatment train we have a portable, modular water treatment solution that delivers the highest performance in disinfection and decontamination, eliminates hard-to-treat micropollutants, and has lower operational costs, capital costs, and energy usage rates than other similar water treatment technologies.

From a monetization standpoint, this treatment train can be described as a “test drive” of our business plan for the AOS – we deliver a full treatment solution to a customer in a robust, ruggedized trailer for a free trial period, after which they have the option of keeping the equipment through either lease, purchase, or pay-per-gallon. This is the reason this prototype AOS treatment train truly represents a pivotal moment in the commercialization of the AOS – it’s out of the lab and into the field, where it will soon be earning real money and helping people save on water costs. Furthermore, this pilot system and its integrated on-site laboratory will provide key data and metrics to provide potential customers and is therefore a linchpin for future sales. This is also just our first pre-commercial pilot. Another is being installed at a small brewery in Southern California and it’s also being pulled by industry stakeholders in areas like stormwater, food & beverage, and petrochemical.

It has been a long journey to bring the AOS to this point. It’s worth mentioning that even multi-billion-dollar technology development companies take many years to invent, develop, and commercialize a new water treatment system, and that’s part of why we’re so proud of getting to where we are now with the AOS. At this milestone, it’s worth reflecting on the journey our water technology team has undertaken to bring this technology to bear.


The Early Days of the AOS

Many of you may remember the beginnings of the AOS. The technology was invented by BioLargo’s Chief Science Officer Ken Code. Ken recognized three things: 1) that current water treatment technologies struggled to contend with certain contaminants and pathogens, leading to public health incidents, 2) existing systems were usually very costly and very energy-intensive, and 3) the industry was using the same handful of technologies to treat water virtually everywhere, with little innovation – UV systems, ozone, hydrogen peroxide systems, and chlorine-based systems. Ken conceived of a new technology that exploits electrochemical principles to deliver novel, highly oxidative iodine chemistry that rapidly kills pathogens and oxidizes contaminants. The AOS was born.
















The very first AOS devices bore little resemblance to today’s AOS. Its job was to demonstrate the principle that advanced carbon materials combined with iodine electrochemistry would result in rapid disinfection and decontamination.

Next, the first real lab-scale AOS prototypes were made. Their purpose was to show that the AOS process works in flowing water (we call this a “flow-through reactor”). These were small, fragile, and slow, but they were shown to exhibit tremendous disinfection and decontamination rates in flowing water while consuming surprisingly little electricity.


























The AOS’ Adolescent Years

The next AOS prototypes that were made were a bit bigger – approximate 3” in diameter. These were made to prove that the AOS technology was scalable with size, and that the performance we saw with the smaller reactors wasn’t an artefact of their small size. These new AOS prototypes were capable of processing up to 1L per minute (0.25 gallons). They didn’t win any beauty contests, but they achieved their goal.


























The next step in AOS development was a big one – our first pre-commercial prototype. The purpose of this was to demonstrate that the AOS could be scaled to a size relevant to water treatment in a real, albeit small, commercial setting. It also needed to be equipped with on-board sensor systems that could measure water quality parameters, flow rate, and pressure. To accomplish this, we partnered with an incredibly talented team of sensor developers at the Northern Alberta Institute of Technology’s (NAIT) Centre for Sensors and System Integration (CSSI) in Edmonton. With NAIT, we built the first Alpha Prototype, complete with state-of-the-art sensors, which we showcased at our technical symposium in August of 2016.


















Soon after this, the BioLargo Water team began to work on a new iteration of the AOS – the “Spiral AOS”. This prototype is designed for interior water treatment applications where space is more of a concern and where a compact water treatment platform is preferable. We showcased the AOS late last year on our blog, and you can learn more about it there! The conventional “Stacked” AOS is still used for applications where space is a less important consideration (for example, at a poultry farm). Thanks in part to the modularity of the Spiral design AOS, the technology is now scalable to nearly any required flowrate by adding increasing the number of AOS reactors in a treatment train.


















All Grown Up

The next step in the development of the AOS was to convert this pre-commercial prototype into a packaged device that could actually be used in a field setting. This meant designing what’s referred to as a “treatment train” – meaning all the equipment required to pump, filter, pre-treat, and post-treat the water so that it meets discharge standards and the client doesn’t have to think about it. This was an arduous step, requiring significant capital resources to create the full treatment train you see here. At this stage we also looked to secure agreements with livestock facilities interested in a pre-commercial pilot project. Our treatment train is now installed on-site at Sunworks Farm, a certified organic chicken farm in Alberta interested in the eco-friendly and innovative nature of our AOS technology.


















All of this work could never have been possible without the generous support of government funding agencies like NRC-IRAP, NSERC, Alberta Innovates, and Southern California’s MWD-ICP program. Grants from these organizations helped pay for salaries, equipment, consumables, lab space, office space, and important research collaborations. All in, BioLargo Water has received more than 60 grants to fund its R&D work on the AOS thus far.

Where does the AOS go from here? Another common refrain we hear from our followers and investors is, “When does this thing start making money?” The question is fair enough. Now, thanks to this pilot (and those soon to come), the answer is easier – “Soon.” Pre-commercial pilots like this one are the last stop on the road before commercial pilots, also known as commercial trials. In this pilot we are refining our technical offering at the commercial scale and refining our business model, wherein we offer customers modular, portable treatment trains that simply solve their water issues. Certainly, the journey is not yet over for the commercialization of the AOS that Ken Code invented years ago, but it’s plain to see that the technology has traveled far to get where it is today, and that the journey is nearly over. We couldn’t be more excited for the future of the AOS.
















Tuesday, 30 April 2019

BioLargo Engineering Awarded EPA Grant to Develop Methods to Remove Toxic Contaminants from Water


WESTMINSTER, CA / ACCESSWIRE / April 30, 2019 / BioLargo, Inc. (OTCQB: BLGO), a technology innovator and full service environmental engineering solutions provider, announced today that its engineering subsidiary had been awarded an SBIR Phase I Competitive Grant by the Environmental Protection Agency in the amount of $100,000 to investigate solutions for the removal of per- and polyfluoroalkyl substances (PFAS) from water. PFAS have been linked to cancer, fertility problems, asthma, and more, and are present in a vast range of manufactured goods including food, common household products (e.g., cleaning products, cookware), and electronics. PFAS also pose widespread and serious water safety problems around the world, with governments and industry actively seeking new technologies and processes to eliminate PFAS from groundwater and drinking water.
The mission of the SBIR (Small Business Innovation Research) program is to support scientific excellence and technological innovation through the investment of Federal research funds in technologies that have the potential for commercialization. The objective of ''Phase I'' research grants are to establish the technical merit, feasibility, and commercial potential of the proposed research and development efforts, and to determine the quality of performance of the small business awardee organization prior to providing further Federal support.





Randall Moore, President of BLEST commented, ''the removal of PFAS contaminants from water presents an important and very difficult challenge. Our team's extensive work in environmental engineering and remediation combined with our comprehensive work in electro-chemistry, advanced oxidation processes and advanced water treatment solutions combine to make our team uniquely qualified to solve issues surrounding environmental PFAS.''
Dennis P. Calvert, President and CEO of BioLargo added, ''This is another example of BioLargo's unique ability to leverage its science and engineering capabilities to deliver innovative real-life solutions to big problems that threaten our water, air and life. We earn the trust of our clients every day by delivering results and value in the most difficult cases. We are also grateful to the US EPA for recognizing our capabilities and supporting our efforts in finding solutions for the removal of PFAS from the environment.''
About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.
Contact Information
Dennis Calvert President and CEO BioLargo, Inc. 800-400-2863 x 2
Safe Harbor Act
This press release includes ''forward-looking statements'' within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as ''expect,'' ''estimate,'' ''project,'' ''budget,'' ''forecast,'' ''anticipate,'' ''intend,'' ''plan,'' ''may,'' ''will,'' ''could,'' ''should,'' ''believes,'' ''predicts,'' ''potential,'' ''continue,'' and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Monday, 29 April 2019

BioLargo Now Serving Cannabis and Hemp Industries via Five-Year Distribution Agreement with Cannabusters

Source: Tamarack Advisors
DENVER, CO / ACCESSWIRE / April 29, 2019 / BioLargo, Inc. announced its recent entry into the lucrative cannabis industry with a five-year white label distribution agreement to supply odor and VOC control products to Cannabusters Inc., a sister company of the Mabre Corporation (Mabre Air Systems), with over 40 years' experience delivering air quality control systems to industry world-wide. Cannabis growing and production facilities are facing increased scrutiny by regulators to better control hazardous air pollutants and odors (from ''terpenes''). These pungent aromas irk neighbors, city officials, and regulators, even as industry seeks to maintain good community relations and avoid legal entanglements and lawsuits over nuisance odors.






Planning and Permitting
Odor mitigation procedures are now a large part of the permitting process for companies considering entering the cannabis industry. With an industry growth rate of 34.6% annually, presenting a thorough and compelling initial application for a grow operation is more important than ever.
There have been a number of high-profile complaints and even fines for several large cultivation facilities. One of the largest cannabis facilities in the world has been the target of complaints from travelers at the nearby Edmonton International Airport and now performs daily aroma audits at its 800,000 square foot facility in a bid to keep the local peace. Two cultivation facilities in Colorado have been fined $2,000 and $14,000 respectively for their failures to remedy odor violations. Another facility on the central coast of California even had its permitted revoked, resulting in 75 jobs being lost. Stories like these highlight the pressing need for a reliable odor control solution in the industry.
BioLargo has a proven track record in eliminating VOCs and related odors in the waste handling industry, and these capabilities translate perfectly to the cannabis odor control industry. From their most recent annual report, ''a number of experts in the cannabis industry tell us that our products could become part of the 'best practices' operating procedures for this industry and are working toward that goal.'' With the global legal cannabis market expected to grow to $146.4B by 2025, and with an estimated 15,000 companies operating in California alone, BioLargo states ''(we) believe the opportunity for our product is significant. To that end, we are organizing a series of strategic relationships within the Cannabis industry to capture the opportunity quickly. We are working to finalize agreements with equipment manufacturers, regulatory consultants, key opinion leaders, and marketing partners. Our value proposition is unmatched for odor and VOC control and this is another great example how our platform continues to expand in high value markets.'' Very encouraging words.



Air Quality & the EPA
Odor is not the only issue. Volatile organic compounds (VOCs) emitted by plants can contribute to smog, a serious issue in places like California and Denver, two cannabis growing hotspots. VOCs, when mixed with nitrogen oxides emitted by automobiles and industrial sources, produce tropospheric ozone, a bluish, irritating and pungent gas that is a major form of smog in the lower atmosphere. Past studies have shown that cannabis plants are a rich source of potent VOCs called ''terpenes'', which give cannabis its distinct odor.
As more legal cannabis growing facilities crop up, the concern over air quality is steadily growing. It has been suggested that the 50,000+ plants being grown in Denver could potentially double the amount of smog-forming VOC's in the area. In fact, Colorado officials recently launched one of the largest studies to date of cannabis farm emissions, concerned that Denver's more than 600 indoor cannabis farms are worsening the city's air pollution, which is already perilously close to and sometimes violates federal limits. Because the EPA doesn't officially recognize the cannabis industry, it doesn't provide the same guidance it does for other industrial emissions. To pick up that slack, researchers aim to use their findings and computer simulations to better understand cannabis related air pollution.






BioLargo's Solution to the Cannabis and Hemp Odor Problem
Carbon filters, which have been the industry's answer to odor control thus far, simply are not doing the job effectively enough, leading to lawsuits and potential headwinds for the cannabis industry as a whole. This is a major problem that needs to be addressed immediately, and one in which BioLargo's state-of-the-art odor and VOC control solution for the waste handling industry may provide a real answer.
BioLargo's solution works by spraying a fine mist of their patented, environmentally safe product onto the stream of air leaving the facility, eliminating odors and VOCs along the way. The efficacy of the product has already been proven, with the four largest waste handling companies in the U.S. using it to control odors and VOCs at their transfer stations, landfills, and other odorous facilities. The product is also supported by BioLargo's in-house engineering services team that includes a host of valuable services to support the grower. The cannabis industry is only the tip of the potential revenue iceberg, as many other industries emit VOCs for which regulators mandate mitigation.
Conclusion
BioLargo's CupriDyne Clean is being positioned currently to be the best and most cost-efficient solution to the cannabis industry's odor and VOC problem. CupriDyne Clean offers a patented, environmentally friendly product platform with applications across multiple industries that deal with odors and VOCs, collectively representing a multi-billion-dollar odor and VOC control market. Having already been proven effective in combating the difficult odors of the solid waste handling industry, where the product is being adopted by several of the largest waste handling companies in the United States, BioLargo through its subsidiary Odor No More, Inc. can apply its award winning technology to the blossoming cannabis industry through their newly minted white label distribution agreement with Cannabusters, Inc.
Given the size and growth rate of the cannabis industry, establishing its CupriDyne Clean as a 'best practices' solution to odor control and its ability to offer critical operations support through its engineering services group has the potential for huge upside with very limited capital requirements.
Legal Disclaimer:
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Flathead Business Solutions LLC, which ownstamarackadvisorsinc.com, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. Flathead Business Solutions LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Flathead Business Solutions LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as ''expects,'' ''will,'' ''anticipates,'' and ''estimates''; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief ''snapshot'' of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov,www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed withwww.otcmarkets.com; (c) for Canadian listed stocks: www.tsx.com and or www.sedar.com (d) obtaining and reviewing publicly available information contained in commonly known search engines such as Google; and (e) consulting investment guides at www.sec.gov andwww.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs atwww.otcmarkets.com. For full disclosure please visit http://tamarackadvisorsinc.com/legal-disclaimer/.
SOURCE: Tamarack Advisors

Monday, 22 April 2019

BioLargo Engineering Cannabis Services

Our intrepid engineering division BioLargo Engineering, Science & Technologies (BLEST) has extensive experience delivering environmental engineering, permitting and training services to countless industries. Today we want to highlight the services they offer to operators in the cannabis and hemp industries. BLEST’s environmental engineering services even have the potential to cross-fertilize (if you’ll excuse the pun) the odor control product sales work our new distributor partner is doing in the cannabis and hemp industries with our patented odor and VOC control products.

You can read about their list of cannabis-related services in their brochure here: https://bit.ly/2Gph7GV

Their engineering services for the cannabis and hemp industries include areas like:
  • Planning and Permitting
  • Training and OSHA
  • Waste Management
  • Air Quality
  • Water and Wastewater
Source: Inc.com











This is an enormous market in the US and has ever-increasing engineering needs. The global legal cannabis market is expected to grow to $146B by 2025 at an astounding 34.6% annual growth rate. In California alone there are more than 9,000 licensed growers and processors according to CalCannabis, making it an important industry for our seasoned engineering term to serve.


Monday, 15 April 2019

BioLargo's Odor-No-More Enters Cannabis and Hemp Odor Control Industry with Experienced Distribution Partner Through White Label Agreement

WESTMINSTER, CA / ACCESSWIRE / April 15, 2019 / BioLargo, Inc. (OTCQB: BLGO), developer of sustainable products and technologies and a full-service environmental engineering company, today announced that its wholly-owned subsidiary Odor-No-More, Inc. had entered into a five-year white label distribution agreement to supply odor and VOC control products to the cannabis and hemp industries with Cannabusters, Inc. (www.thecannabusters.com).






Cannabusters is an odor solutions provider comprised of experts with decades of air quality control experience through their sister company Mabre Corporation. Cannabusters was formed to leverage BioLargo's patented CupriDyne Clean technology in its aggressive push into the cannabis and hemp industries because of the product's record of unparalleled performance and safety serving customers in the waste handling industry.
Cannabusters has committed to a comprehensive marketing program that includes more than 25 trade show events over the next two years to quickly introduce the Cannabusters product to the cannabis and hemp industries. BioLargo's subsidiary Odor-No-More has committed to manufacture and supply its products containing the patented CupriDyne Clean formula to be distributed under the "CannabustersTM" brand.
Cannabusters, Inc. President Dominic Paulhus commented, "There has been an explosion of cannabis grow operations across North America over the past few years. We have watched the industry struggle to control the odors that naturally come with cannabis production. With CannabustersTM our goal was to provide a state-of-the-art odor and VOC control solution for cannabis and hemp growers who won't put up with non-performing products. We identified CupriDyne Clean as the best chemistry product for this goal because of its track record in industries with tough odors and the knowledge and expertise of the Odor-No-More team. We're proud to announce this partnership."
BioLargo President & CEO Dennis P. Calvert commented, "The legal cannabis market is still rapidly evolving in the US and we are just now learning the magnitude of the opportunity for odor control in this market. In our backyard in California, there are more than 5,000 licensed mixed-light and indoor growing facilities according to the licensing body CalCannabis. Our experience and internal calculations show that a typical 10,000 sq ft facility may use, conservatively, $5,000 of product or more per month. This figure does not include install, service, maintenance, or equipment revenues. Given the fact that the state of California alone received applications for nearly 20,000 cultivation licenses in 2018, we believe the market for cannabis cultivation odor control will grow dramatically in the next few years - and that's only California."
Odor-No-More, Inc. President Joseph Provenzano said, "Cannabusters, Inc. has an exceptionally qualified team and we look forward to leveraging the CupriDyne Clean formula and our existing infrastructure into this large and emerging industry under the Cannabusters brand. Within the cannabis and hemp industries, we have identified a number of key relationships to complement this agreement and are working to finalize new agreements with equipment manufacturers, regulatory consultants, key opinion leaders, and marketing partners. Our value proposition is unmatched for odor and VOC control and this is another great example of how our platform continues to expand in high-value markets."

###

BioLargo's CupriDyne Clean is an award winning and environmentally friendly formula that eliminates odors and volatile organic compounds "VOCs" without the need for fragrances and other masking agents.




The Company's role in rapidly growing emerging markets like the Cannabis industry has been coined a "Pick and Shovel Play" as the company supplies critical tools to help industry members optimize their operations.



About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.
Contact Information
Dennis Calvert President and CEO BioLargo, Inc. 800-400-2863
Safe Harbor Act
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," 'will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
SOURCE: BioLargo, Inc.